weaning off percocet with ultram
Comparative Table for Ultram Prices
Johnson & Johnson lost a court battle last week to prevent Caraco Pharmaceutical Laboratories from making a generic version of its Ultracet painkiller. The drug generated sales of $320 million for New Brunswick-based J&J last year, according to the consulting firm NDC Health, but it will now face competition from three generic versions. Caraco won a ruling from a federal judge in Detroit, where it is based, that making a generic version of the drug would not infringe on Johnson & Johnson's patent. The drug combines acetaminophen, the main ingredient in Johnson & Johnson's Tylenol, with tramadol hydrochloride, a compound used in the painkiller Ultram. Related Results Mitchell to Enhance Re-Key Solutions General Casualty Insurance Extends Agreement With Mitchell for Comprehensive...
Next partNAME CONFUSION
Move over, Percocet (oxycodone and acetaminophen). Another analgesic with a dangerously similar name-Procet (hydrocodone bitartrate and acetaminophen)-is on the market. The name of a third analgesic, Parlor DC (acetaminophen, caffeine, and dihydrocodeine), looks and sounds like that of Pamelor (nortriptyline), a tricyclic antidepressant. A loophole in FDA regulations allowed Procet and Parlor to reach the market without a premarketing trademark review. Related Results
NortriptylineNortriptyline and smokingNortriptyline and neuropathic painNortriptyline may aid ECT efficacyNortriptyline may beat SSRIs for depression in Parkinson's
Your facility should avoid having both Procet and Percocet on the drug formulary.
Johnson & Johnson said yesterday that it has begun construction of a $181 million building at its Spring House complex that will add 120 jobs and become the East Coast "hub" for its early-stage drug-discovery research and development. The 150,000-square-foot building will add laboratories, clinical development and office space. It is scheduled to be completed in 2009. Johnson & Johnson Pharmaceutical Research & Development L. L. C.now employs 680 in Spring House, where the company said prescription medicines, including Topamax, Ultram and Ultracet, were developed. Most Popular
Public Speaking: 7 Secrets Of Great Public Speakers
13 Job Interview Mistakes To Avoid
10 Jobs That Pay $30 An Hour
5 Regular Mistakes In Public Speaking
3 Questions No Job Seeker Ever Wants To Be Asked?
"This expansion demonstrates our commitment to, and support of, research and development as a critical component of our future success," Joseph C.